Tacrolimus and pimecrolimus: better options for paediatric AD

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1281, 2001-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Boxed warning recommended for tacrolimus/pimecrolimus

Reactions Weekly, Vol. 1, Iss. 1040, 2005-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Topical Calcineurin Inhibitors, Pimecrolimus and Tacrolimus

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 6, Iss. 3, 2007-01 ,pp. : 237-243

Bentham Science Publishers

Access to resources Recommend Favorite

Tacrolimus beneficial in paediatric vitiligo

Inpharma, Vol. 1, Iss. 1394, 2003-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Treatment options for paediatric diabetes

By Verrotti Alberto Chiuri Rosa Maria Blasetti Annalisa Mohn Angelika Chiarelli Francesco

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 15, 2010-10 ,pp. : 2483-2495

Informa Healthcare

Access to resources Recommend Favorite

Pimecrolimus: Allergic contact dermatitis in a patient with tacrolimus allergy: case report

Reactions Weekly, Vol. 1, Iss. 1137, 2007-01 ,pp. : 22-23

Adis International

Access to resources Recommend Favorite